Harnessing AI and Genomics in Clinical Trial Enrollment
Update: 2025-06-26
Description
The Dana-Farber Cancer Institute (DFCI)’s MatchMiner tool was developed to increase historically low clinical trial enrollment rates in adults with cancer. Roy Perlis, MD, MSc, Editor in Chief of JAMA+ AI, spoke with Kenneth Kehl, MD, MPH, about his recent study published in JAMA Network Open evaluating the AI tool’s ability to fulfill its purpose through genome sequencing.
Related Content:
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
